Novel coronavirus (SARS-CoV-2) infection in a patient with multivisceral transplant

Coronavirus disease 2019 (COVID-19) pandemic has become one of the most challenging episodes in the history of modern public health, with particular emphasis in high-risk population. However, the evidence regarding their response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), t...

Descripción completa

Autores: Papa Gobbi, Rodrigo; Bueno, Alba; Serradilla, J; Talayero, Paloma; Stringa, Pablo Luis; Pascual Miguel, Bárbara; Alcolea Sánchez, Alida; González Sacristan, Rocío; Andres, Ane M.; López Santamaría, Manuel; Rumbo, Martín; Ramos Boluda, Esther; Hernández Oliveros, Francisco
Tipo de documento: Artículo
Estado:Published version
Fecha de publicación:2020
País:Argentina
Institución:UNLP
Repositorio:SEDICI (UNLP)
Lenguaje:Inglés
OAI Identifier:oai:sedici.unlp.edu.ar:10915/125785
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/125785
Nivel de acceso:Acceso abierto
Palabra clave:Ciencias Médicas
Virology
Coronavirus
Immunosuppression
Severe acute respiratory syndrome coronavirus
Transplantation
2019-20 coronavirus outbreak
Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
Coronavirus disease 2019 (covid-19)
Multivisceral transplantation
Medicine
Sumario:Coronavirus disease 2019 (COVID-19) pandemic has become one of the most challenging episodes in the history of modern public health, with particular emphasis in high-risk population. However, the evidence regarding their response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for COVID-19 is scant. Herein, we present the clinical and therapeutic course of a SARS-CoV-2 infection in a patient with multivisceral transplant and a recent tuberculosis infection.

Ejemplares similares